TGFB1 and neoplasm: Importantly, NK cell-specific deletion of the TGFβ type II receptor (TGFβRII) causes enhanced anti-tumor activity in multiple mouse models of metastasis, whereas constitutive TGFβ signaling arrests NK cell development and drives increased tumor growth [110].